These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Role of EIPV in 1988 Israel polio outbreak. Slater PE. Vaccine; 1994 Apr; 12(5):476. PubMed ID: 8023559 [No Abstract] [Full Text] [Related]
3. A ten-year experience in control of poliomyelitis through a combination of live and killed vaccines in two developing areas. Tulchinsky T, Abed Y, Shaheen S, Toubassi N, Sever Y, Schoenbaum M, Handsher R. Am J Public Health; 1989 Dec; 79(12):1648-52. PubMed ID: 2817193 [Abstract] [Full Text] [Related]
7. Development and introduction of inactivated poliovirus vaccines derived from Sabin strains in Japan. Shimizu H. Vaccine; 2016 Apr 07; 34(16):1975-85. PubMed ID: 25448090 [Abstract] [Full Text] [Related]
11. Polio vaccines and polio immunization in the pre-eradication era: WHO position paper. Wkly Epidemiol Rec; 2010 Jun 04; 85(23):213-28. PubMed ID: 20545051 [No Abstract] [Full Text] [Related]
15. Polio eradication in India: how far are we from reaching the goal? Banerjee K, Sahu S, Bandyopadhyay S. Indian J Pediatr; 2001 Mar 04; 68 Suppl 1():S6-14. PubMed ID: 11411387 [No Abstract] [Full Text] [Related]
16. Decision analysis in planning for a polio outbreak in the United States. Jenkins PC, Modlin JF. Pediatrics; 2006 Aug 04; 118(2):611-8. PubMed ID: 16882814 [Abstract] [Full Text] [Related]
18. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis. Pliaka V, Kyriakopoulou Z, Markoulatos P. Expert Rev Vaccines; 2012 May 04; 11(5):609-28. PubMed ID: 22827246 [Abstract] [Full Text] [Related]